Skip to content

Study · Measured the body's own peptide · 2016

1 result

Plasma levels of F-actin and F:G-actin ratio as potential new biomarkers in patients with septic shock.

Belsky JB, Morris DC, Bouchebl R, Filbin MR, Bobbitt KR, Jaehne AK, Rivers EP

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals12 Jan 2016Cited by 17 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In people with septic shock or noninfectious SIRS, the body's own Tβ4 in plasma was not detectable above the assay's lowest detection range.

    In plain wordsIn people with septic shock or noninfectious SIRS, the body's own Tβ4 in blood plasma was too low to detect with this assay.

    Outcome
    Not applicablePlasma Tβ4 detection in septic shock and SIRS
    Study

    n: not reported in source

    Outcome group
    Inflammation markers · Immune and inflammation

    Measurements

    Assay lowest detection range
    78 ng/ml
    plasma Tβ4 assay

    Source sentences

    Summary
    TB4 was not detectable in the septic shock or noninfectious SIRS group above the assay's lowest detection range (78 ng/ml).
    1 context sentence
    Summary · context
    To compare plasma levels of F-actin, G-actin and thymosin beta 4 (TB4) in humans with septic shock, noninfectious systemic inflammatory response syndrome (SIRS) and healthy controls.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.